Company intelligence / Profile preview

Kind Therapeutics USA

Hagerstown, Maryland, United Stateskindtherapeuticsusa.com ↗

Ownership: Private
Development stage: Commercial

Overview

Kind Therapeutics USA operates a commercial-scale indoor cultivation and processing facility for premium-quality medical cannabis. Their products are lab-tested for potency and purity and distributed to certified patients via dispensaries across Maryland. The company emphasizes precision dosing, strain validation, and partnerships with medical professionals to ensure safe access to medicinal cannabis.

Therapeutic areas: Neurology
Modalities: Plant-derived therapyCannabis-based medicine
Industry: Agriculture & AgTech

Drug pipeline

3 assets

Nature's Heritage

Commercial

Indications: Pain, Sleep disorders

2 more assets in the full pipeline.

Request access →

Partnerships

MariMed Inc. (management/development partner prior to acquisition; now parent company)

Beyond the preview

Go deeper on Kind Therapeutics USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kind Therapeutics USA.

Explore the full profile